Published in Nursing Home and Elder Business Week, June 10th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Biotechnology Industry Organization (BIO).
Report 1: The Biotechnology Industry Organization (BIO) opposes the Chairman's Mark to the Medicare Prescription Drug Price Negotiation Act of 2007 (S. 3) which is being considered by the Senate Committee on Finance today.
The Chairman's Mark to S. 3 repeals the language in the Medicare Modernization Act which prohibits the federal government from interfering with the negotiations between drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week